Valuation: Vitrolife AB

Capitalization 19.53B 2.04B 1.75B 1.63B 1.51B 2.8B 175B 3.13B 7.41B 81.83B 7.67B 7.51B 300B P/E ratio 2025 *
37.1x
P/E ratio 2026 * 28x
Enterprise value 19.7B 2.06B 1.76B 1.64B 1.52B 2.82B 177B 3.16B 7.48B 82.55B 7.74B 7.58B 303B EV / Sales 2025 *
5.44x
EV / Sales 2026 * 4.75x
Free-Float
55.41%
Yield 2025 *
0.76%
Yield 2026 * 0.92%
More valuation ratios * Estimated data
Dynamic Chart
1 week+1.49%
Current month+2.43%
1 month-7.96%
3 months-6.52%
6 months-32.17%
Current year-33.30%
More quotes
1 week 139
Extreme 139
148
1 month 134.4
Extreme 134.4
160.7
Current year 134.4
Extreme 134.4
251
1 year 134.4
Extreme 134.4
268
3 years 123.9
Extreme 123.9
332.6
5 years 123.9
Extreme 123.9
585
10 years 30.3
Extreme 30.3
585
More quotes
Manager TitleAgeSince
Chief Executive Officer 51 31/07/2023
Director of Finance/CFO 60 02/12/2024
Chief Tech/Sci/R&D Officer - 31/12/2021
Director TitleAgeSince
Director/Board Member 62 18/04/2013
Chairman 69 31/07/2023
Director/Board Member 65 26/04/2018
More insiders
Name Weight AuM 1st Jan change
0.37% 239 M€ -1.47% -
More ETFs: Vitrolife AB
Change 5d. change 1-year change 3-years change Capi.($)
-0.55%+1.49%-16.24%-46.33% 2.06B
-0.17%+1.45%+29.35%+13.66% 16.49B
+0.49%+0.68% - - 7.37B
+2.70%+0.20%+84.29%+0.83% 6.14B
-0.18%-2.94%-12.69%+23.43% 6.04B
-0.11%-2.71%-9.09%-34.33% 5.65B
+4.71%+4.70%+5.49%+22.66% 5.48B
-0.29%+0.80%-15.87%-25.15% 3.02B
+0.44%+0.19%-9.14%-40.02% 2.25B
+0.10%+0.78%+15.57%-30.67% 1.65B
Average +0.76%-0.55%+7.96%-12.88% 5.61B
Weighted average by Cap. +0.74%-0.97%+16.96%-0.20%
See all sector performances

Financials

2025 *2026 *
Net sales 3.62B 379M 324M 303M 280M 519M 32.56B 582M 1.38B 15.19B 1.42B 1.39B 55.71B 4B 418M 357M 334M 308M 573M 35.9B 641M 1.52B 16.75B 1.57B 1.54B 61.43B
Net income 526M 55.12M 47.08M 43.94M 40.64M 75.42M 4.73B 84.49M 200M 2.21B 207M 202M 8.09B 697M 72.97M 62.32M 58.17M 53.8M 99.85M 6.26B 112M 265M 2.92B 274M 268M 10.71B
Net Debt 174M 18.22M 15.56M 14.52M 13.43M 24.93M 1.56B 27.92M 66.04M 729M 68.32M 66.91M 2.67B -539M -56.39M -48.17M -44.96M -41.58M -77.16M -4.84B -86.45M -204M -2.26B -212M -207M -8.28B
More financial data * Estimated data
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,150
More about the company
Date Price Change Volume
08/07/25 143.40 kr -0.55% 104,760
07/07/25 144.20 kr -0.07% 140,544
04/07/25 144.30 kr +0.35% 76,463
03/07/25 143.80 kr +0.42% 76,770
02/07/25 143.20 kr +1.34% 68,664

Delayed Quote Nasdaq Stockholm, July 08, 2025 at 05:00 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
144.20SEK
Average target price
228.75SEK
Spread / Average Target
+58.63%
Consensus

Quarterly revenue - Rate of surprise